+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Vial Adaptors for Reconstitution Drug Market 2022-2026

  • PDF Icon

    Report

  • 120 Pages
  • February 2022
  • Region: Global
  • TechNavio
  • ID: 5550383
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The publisher has been monitoring the vial adaptors for reconstitution drug market and it is poised to grow by $ 460.98 mn during 2022-2026, progressing at a CAGR of 7.57% during the forecast period. This report on the vial adaptors for reconstitution drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the growing prevalence of chronic conditions, widening pool of geriatrics, and growing awareness about the advantages of using vial adaptors.

The vial adaptors for reconstitution drug market analysis includes the therapeutic area segment and geographic landscape.

The publisher's vial adaptors for reconstitution drug market is segmented as below:


By Therapeutic Area


  • Infectious diseases
  • Autoimmune diseases
  • Metabolic conditions
  • Others

By Geographical Landscape


  • North America
  • Europe
  • Asia
  • Rest of World (ROW)

This study identifies the fluctuating prices of raw materials used in vial adaptors manufacturing as one of the prime reasons driving the vial adaptors for reconstitution drug market growth during the next few years. Also, the growing demand for lyophilized drugs and increasing adoption of technology will lead to sizable demand in the market.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters.

This report on vial adaptors for reconstitution drug market covers the following areas:


  • Vial adaptors for reconstitution drug market sizing
  • Vial adaptors for reconstitution drug market forecast
  • Vial adaptors for reconstitution drug market industry analysis

The publisher's robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading vial adaptors for reconstitution drug market vendors that include Agilent Technologies Inc., Amsino International Inc., B. Braun Melsungen AG, Becton Dickinson and Co., Cole-Parmer Instrument Co. LLC, Corvida Medical, Dedecke GmbH, Helapet ltd., Medtec Medical Inc, Merck KGaA, Mettler Toledo International Inc., Miltenyi Biotec B.V. and Co. KG, Raygroup SASU, Shimadzu Corp., Simplivia, Stevanato Group S.p.A, Thermo Fisher Scientific Inc., West Pharmaceutical Services Inc., and Healthmark Industries Company Inc. Also, the vial adaptors for reconstitution drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The publisher's market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Therapeutic Area
Exhibit 06: Executive Summary - Chart on Incremental Growth
Exhibit 07: Executive Summary - Data Table on Incremental Growth
Exhibit 08: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape
2.1 Market ecosystem
Exhibit 09: Parent market
Exhibit 10: Market Characteristics
3 Market Sizing
3.1 Market definition
Exhibit 11: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 12: Market segments
3.3 Market size 2021
3.4 Market outlook: Forecast for 2021-2026
Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)
4 Five Forces Analysis
4.1 Five forces summary
Exhibit 17: Five forces analysis - Comparison between 2021 and 2026
4.2 Bargaining power of buyers
Exhibit 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026
4.3 Bargaining power of suppliers
Exhibit 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026
4.4 Threat of new entrants
Exhibit 20: Threat of new entrants - Impact of key factors in 2021 and 2026
4.5 Threat of substitutes
Exhibit 21: Threat of substitutes - Impact of key factors in 2021 and 2026
4.6 Threat of rivalry
Exhibit 22: Threat of rivalry - Impact of key factors in 2021 and 2026
4.7 Market condition
Exhibit 23: Chart on Market condition - Five forces 2021 and 2026
5 Market Segmentation by Therapeutic Area
5.1 Market segments
Exhibit 24: Chart on Therapeutic Area - Market share 2021-2026 (%)
Exhibit 25: Data Table on Therapeutic Area - Market share 2021-2026 (%)
5.2 Comparison by Therapeutic Area
Exhibit 26: Chart on Comparison by Therapeutic Area
Exhibit 27: Data Table on Comparison by Therapeutic Area
5.3 Infectious diseases - Market size and forecast 2021-2026
Exhibit 28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibit 31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)
5.4 Autoimmune diseases - Market size and forecast 2021-2026
Exhibit 32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
Exhibit 35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%)
5.5 Metabolic conditions - Market size and forecast 2021-2026
Exhibit 36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibit 37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million)
Exhibit 38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%)
Exhibit 39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%)
5.6 Others - Market size and forecast 2021-2026
Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)
5.7 Market opportunity by Therapeutic Area
Exhibit 44: Market opportunity by Therapeutic Area ($ million)
6 Customer Landscape
6.1 Customer landscape overview
Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
7 Geographic Landscape
7.1 Geographic segmentation
Exhibit 46: Chart on Market share By Geographical Landscape 2021-2026 (%)
Exhibit 47: Data Table on Market share By Geographical Landscape 2021-2026 (%)
7.2 Geographic comparison
Exhibit 48: Chart on Geographic comparison
Exhibit 49: Data Table on Geographic comparison
7.3 North America - Market size and forecast 2021-2026
Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)
7.4 Europe - Market size and forecast 2021-2026
Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)
7.5 Asia - Market size and forecast 2021-2026
Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)
7.6 Rest of World (ROW) - Market size and forecast 2021-2026
Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
7.7 US - Market size and forecast 2021-2026
Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)
7.8 Germany - Market size and forecast 2021-2026
Exhibit 70: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 72: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 73: Data Table on Germany - Year-over-year growth 2021-2026 (%)
7.9 UK - Market size and forecast 2021-2026
Exhibit 74: Chart on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 75: Data Table on UK - Market size and forecast 2021-2026 ($ million)
Exhibit 76: Chart on UK - Year-over-year growth 2021-2026 (%)
Exhibit 77: Data Table on UK - Year-over-year growth 2021-2026 (%)
7.10 China - Market size and forecast 2021-2026
Exhibit 78: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 79: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 80: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 81: Data Table on China - Year-over-year growth 2021-2026 (%)
7.11 Japan - Market size and forecast 2021-2026
Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)
7.12 Market opportunity By Geographical Landscape
Exhibit 86: Market opportunity By Geographical Landscape ($ million)
8 Drivers, Challenges, and Trends
8.1 Market drivers
8.2 Market challenges
8.3 Impact of drivers and challenges
Exhibit 87: Impact of drivers and challenges in 2021 and 2026
8.4 Market trends
9 Vendor Landscape
9.1 Overview
9.2 Vendor landscape
Exhibit 88: Overview on Criticality of inputs and Factors of differentiation
9.3 Landscape disruption
Exhibit 89: Overview on factors of disruption
9.4 Industry risks
Exhibit 90: Impact of key risks on business
10 Vendor Analysis
10.1 Vendors covered
Exhibit 91: Vendors covered
10.2 Market positioning of vendors
Exhibit 92: Matrix on vendor position and classification
10.3 Agilent Technologies Inc.
Exhibit 93: Agilent Technologies Inc. - Overview
Exhibit 94: Agilent Technologies Inc. - Business segments
Exhibit 95: Agilent Technologies Inc. - Key news
Exhibit 96: Agilent Technologies Inc. - Key offerings
Exhibit 97: Agilent Technologies Inc. - Segment focus
10.4 B. Braun Melsungen AG
Exhibit 98: B. Braun Melsungen AG - Overview
Exhibit 99: B. Braun Melsungen AG - Business segments
Exhibit 100: B. Braun Melsungen AG - Key news
Exhibit 101: B. Braun Melsungen AG - Key offerings
Exhibit 102: B. Braun Melsungen AG - Segment focus
10.5 Becton Dickinson and Co.
Exhibit 103: Becton Dickinson and Co. - Overview
Exhibit 104: Becton Dickinson and Co. - Business segments
Exhibit 105: Becton Dickinson and Co. - Key news
Exhibit 106: Becton Dickinson and Co. - Key offerings
Exhibit 107: Becton Dickinson and Co. - Segment focus
10.6 Dedecke GmbH
Exhibit 108: Dedecke GmbH - Overview
Exhibit 109: Dedecke GmbH - Product / Service
Exhibit 110: Dedecke GmbH - Key offerings
10.7 Merck KGaA
Exhibit 111: Merck KGaA - Overview
Exhibit 112: Merck KGaA - Product / Service
Exhibit 113: Merck KGaA - Key offerings
10.8 Miltenyi Biotec B.V. and Co. KG
Exhibit 114: Miltenyi Biotec B.V. and Co. KG - Overview
Exhibit 115: Miltenyi Biotec B.V. and Co. KG - Product / Service
Exhibit 116: Miltenyi Biotec B.V. and Co. KG - Key news
Exhibit 117: Miltenyi Biotec B.V. and Co. KG - Key offerings
10.9 Shimadzu Corp.
Exhibit 118: Shimadzu Corp. - Overview
Exhibit 119: Shimadzu Corp. - Business segments
Exhibit 120: Shimadzu Corp. - Key news
Exhibit 121: Shimadzu Corp. - Key offerings
Exhibit 122: Shimadzu Corp. - Segment focus
10.10 Stevanato Group S.p.A
Exhibit 123: Stevanato Group S.p.A - Overview
Exhibit 124: Stevanato Group S.p.A - Product / Service
Exhibit 125: Stevanato Group S.p.A - Key offerings
10.11 Thermo Fisher Scientific Inc.
Exhibit 126: Thermo Fisher Scientific Inc. - Overview
Exhibit 127: Thermo Fisher Scientific Inc. - Business segments
Exhibit 128: Thermo Fisher Scientific Inc. - Key news
Exhibit 129: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 130: Thermo Fisher Scientific Inc. - Segment focus
10.12 West Pharmaceutical Services Inc.
Exhibit 131: West Pharmaceutical Services Inc. - Overview
Exhibit 132: West Pharmaceutical Services Inc. - Business segments
Exhibit 133: West Pharmaceutical Services Inc. - Key news
Exhibit 134: West Pharmaceutical Services Inc. - Key offerings
Exhibit 135: West Pharmaceutical Services Inc. - Segment focus
11 Appendix
11.1 Scope of the report
11.2 Inclusions and exclusions checklist
Exhibit 136: Inclusions checklist
Exhibit 137: Exclusions checklist
11.3 Currency conversion rates for US$
Exhibit 138: Currency conversion rates for US$
11.4 Research methodology
Exhibit 139: Research methodology
Exhibit 140: Validation techniques employed for market sizing
Exhibit 141: Information sources
11.5 List of abbreviations
Exhibit 142: List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview List of Exhibits
Exhibits 2: Executive Summary - Data Table on Market Overview List of Exhibits
Exhibits 3: Executive Summary - Chart on Global Market Characteristics List of Exhibits
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape List of Exhibits
Exhibits 5: Executive Summary - Chart on Market Segmentation by Therapeutic Area List of Exhibits
Exhibits 6: Executive Summary - Chart on Incremental Growth List of Exhibits
Exhibits 7: Executive Summary - Data Table on Incremental Growth List of Exhibits
Exhibits 8: Executive Summary - Chart on Vendor Market Positioning List of Exhibits
Exhibits 9: Parent market List of Exhibits
Exhibits 10: Market Characteristics List of Exhibits
Exhibits 11: Offerings of vendors included in the market definition List of Exhibits
Exhibits 12: Market segments List of Exhibits
Exhibits 13: Chart on Global - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 14: Data Table on Global - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 15: Chart on Global Market: Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 17: Five forces analysis - Comparison between 2021 and 2026 List of Exhibits
Exhibits 18: Bargaining power of buyers - Impact of key factors in 2021 and 2026 List of Exhibits
Exhibits 19: Bargaining power of suppliers - Impact of key factors in 2021 and 2026 List of Exhibits
Exhibits 20: Threat of new entrants - Impact of key factors in 2021 and 2026 List of Exhibits
Exhibits 21: Threat of substitutes - Impact of key factors in 2021 and 2026 List of Exhibits
Exhibits 22: Threat of rivalry - Impact of key factors in 2021 and 2026 List of Exhibits
Exhibits 23: Chart on Market condition - Five forces 2021 and 2026 List of Exhibits
Exhibits 24: Chart on Therapeutic Area - Market share 2021-2026 (%) List of Exhibits
Exhibits 25: Data Table on Therapeutic Area - Market share 2021-2026 (%) List of Exhibits
Exhibits 26: Chart on Comparison by Therapeutic Area List of Exhibits
Exhibits 27: Data Table on Comparison by Therapeutic Area List of Exhibits
Exhibits 28: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 29: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 30: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 31: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 32: Chart on Autoimmune diseases - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 33: Data Table on Autoimmune diseases - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 34: Chart on Autoimmune diseases - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 35: Data Table on Autoimmune diseases - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 36: Chart on Metabolic conditions - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 37: Data Table on Metabolic conditions - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 38: Chart on Metabolic conditions - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 39: Data Table on Metabolic conditions - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 40: Chart on Others - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 41: Data Table on Others - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 42: Chart on Others - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 43: Data Table on Others - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 44: Market opportunity by Therapeutic Area ($ million) List of Exhibits
Exhibits 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria List of Exhibits
Exhibits 46: Chart on Market share By Geographical Landscape 2021-2026 (%) List of Exhibits
Exhibits 47: Data Table on Market share By Geographical Landscape 2021-2026 (%) List of Exhibits
Exhibits 48: Chart on Geographic comparison List of Exhibits
Exhibits 49: Data Table on Geographic comparison List of Exhibits
Exhibits 50: Chart on North America - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 51: Data Table on North America - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 52: Chart on North America - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 53: Data Table on North America - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 54: Chart on Europe - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 56: Chart on Europe - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 57: Data Table on Europe - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 58: Chart on Asia - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 60: Chart on Asia - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 61: Data Table on Asia - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 66: Chart on US - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 67: Data Table on US - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 68: Chart on US - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 69: Data Table on US - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 70: Chart on Germany - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 71: Data Table on Germany - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 72: Chart on Germany - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 73: Data Table on Germany - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 74: Chart on UK - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 75: Data Table on UK - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 76: Chart on UK - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 77: Data Table on UK - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 78: Chart on China - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 79: Data Table on China - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 80: Chart on China - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 81: Data Table on China - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 82: Chart on Japan - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million) List of Exhibits
Exhibits 84: Chart on Japan - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 85: Data Table on Japan - Year-over-year growth 2021-2026 (%) List of Exhibits
Exhibits 86: Market opportunity By Geographical Landscape ($ million) List of Exhibits
Exhibits 87: Impact of drivers and challenges in 2021 and 2026 List of Exhibits
Exhibits 88: Overview on Criticality of inputs and Factors of differentiation List of Exhibits
Exhibits 89: Overview on factors of disruption List of Exhibits
Exhibits 90: Impact of key risks on business List of Exhibits
Exhibits 91: Vendors covered List of Exhibits
Exhibits 92: Matrix on vendor position and classification List of Exhibits
Exhibits 93: Agilent Technologies Inc. - Overview List of Exhibits
Exhibits 94: Agilent Technologies Inc. - Business segments List of Exhibits
Exhibits 95: Agilent Technologies Inc. - Key news List of Exhibits
Exhibits 96: Agilent Technologies Inc. - Key offerings List of Exhibits
Exhibits 97: Agilent Technologies Inc. - Segment focus List of Exhibits
Exhibits 98: B. Braun Melsungen AG - Overview List of Exhibits
Exhibits 99: B. Braun Melsungen AG - Business segments List of Exhibits
Exhibits 100: B. Braun Melsungen AG - Key news List of Exhibits
Exhibits 101: B. Braun Melsungen AG - Key offerings List of Exhibits
Exhibits 102: B. Braun Melsungen AG - Segment focus List of Exhibits
Exhibits 103: Becton Dickinson and Co. - Overview List of Exhibits
Exhibits 104: Becton Dickinson and Co. - Business segments List of Exhibits
Exhibits 105: Becton Dickinson and Co. - Key news List of Exhibits
Exhibits 106: Becton Dickinson and Co. - Key offerings List of Exhibits
Exhibits 107: Becton Dickinson and Co. - Segment focus List of Exhibits
Exhibits 108: Dedecke GmbH - Overview List of Exhibits
Exhibits 109: Dedecke GmbH - Product / Service List of Exhibits
Exhibits 110: Dedecke GmbH - Key offerings List of Exhibits
Exhibits 111: Merck KGaA - Overview List of Exhibits
Exhibits 112: Merck KGaA - Product / Service List of Exhibits
Exhibits 113: Merck KGaA - Key offerings List of Exhibits
Exhibits 114: Miltenyi Biotec B.V. and Co. KG - Overview List of Exhibits
Exhibits 115: Miltenyi Biotec B.V. and Co. KG - Product / Service List of Exhibits
Exhibits 116: Miltenyi Biotec B.V. and Co. KG - Key news List of Exhibits
Exhibits 117: Miltenyi Biotec B.V. and Co. KG - Key offerings List of Exhibits
Exhibits 118: Shimadzu Corp. - Overview List of Exhibits
Exhibits 119: Shimadzu Corp. - Business segments List of Exhibits
Exhibits 120: Shimadzu Corp. - Key news List of Exhibits
Exhibits 121: Shimadzu Corp. - Key offerings List of Exhibits
Exhibits 122: Shimadzu Corp. - Segment focus List of Exhibits
Exhibits 123: Stevanato Group S.p.A - Overview List of Exhibits
Exhibits 124: Stevanato Group S.p.A - Product / Service List of Exhibits
Exhibits 125: Stevanato Group S.p.A - Key offerings List of Exhibits
Exhibits 126: Thermo Fisher Scientific Inc. - Overview List of Exhibits
Exhibits 127: Thermo Fisher Scientific Inc. - Business segments List of Exhibits
Exhibits 128: Thermo Fisher Scientific Inc. - Key news List of Exhibits
Exhibits 129: Thermo Fisher Scientific Inc. - Key offerings List of Exhibits
Exhibits 130: Thermo Fisher Scientific Inc. - Segment focus List of Exhibits
Exhibits 131: West Pharmaceutical Services Inc. - Overview List of Exhibits
Exhibits 132: West Pharmaceutical Services Inc. - Business segments List of Exhibits
Exhibits 133: West Pharmaceutical Services Inc. - Key news List of Exhibits
Exhibits 134: West Pharmaceutical Services Inc. - Key offerings List of Exhibits
Exhibits 135: West Pharmaceutical Services Inc. - Segment focus List of Exhibits
Exhibits 136: Inclusions checklist List of Exhibits
Exhibits 137: Exclusions checklist List of Exhibits
Exhibits 138: Currency conversion rates for US$ List of Exhibits
Exhibits 139: Research methodology List of Exhibits
Exhibits 140: Validation techniques employed for market sizing List of Exhibits
Exhibits 141: Information sources List of Exhibits
Exhibits 142: List of abbreviations

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Agilent Technologies Inc.
  • Amsino International Inc.
  • B. Braun Melsungen AG
  • Becton Dickinson and Co.
  • Cole-Parmer Instrument Co. LLC
  • Corvida Medical
  • Dedecke GmbH
  • Helapet ltd.
  • Medtec Medical Inc
  • Merck KGaA
  • Mettler Toledo International Inc.
  • Miltenyi Biotec B.V. and Co. KG
  • Raygroup SASU
  • Shimadzu Corp.
  • Simplivia
  • Stevanato Group S.p.A
  • Thermo Fisher Scientific Inc.
  • West Pharmaceutical Services Inc.
  • Healthmark Industries Company Inc.